(Q63321114)
Statements
GATE (English)
0 references
Multi-centre, Randomized, Double-blind, Placebo-controlled, Parallel-group, 9 Month, Equivalence Trial Comparing the Efficacy and Safety and Tolerability of GTR (Synthon BV) to Copaxone® (Teva) in Subjects With Relapsing Remitting Multiple Sclerosis Followed by an Open-label 15 Month GTR Treatment Part Evaluating the Long-term GTR Treatment Effects (English)
0 references
October 2011
0 references
January 2015
0 references
794
0 references
18 year
0 references
55 year
0 references